During the past decade, Arthritis Center of Reno conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 8 clinical trials were completed, i.e. on average, 800% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis Center of Reno" #1 sponsor was "Merrimack Pharmaceuticals" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Angiotech Pharmaceuticals" with 1 trials sponsored, "Anika Therapeutics, Inc." with 1 trials sponsored and "BioCryst Pharmaceuticals" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Center of Reno" #1 collaborator was "BARC Global Central Laboratory" with 1 trials as a collaborator, "Bilcare Global Clinical Supplies" with 1 trials as a collaborator, "Camargo Pharmaceutical Services" with 1 trials as a collaborator, "Clin Data Services" with 1 trials as a collaborator and "Harrison Clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Center of Reno" are "Rheumatoid Arthritis" (10 trials), "Arthritis, Rheumatoid" (4 trials), "Gout" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Arthritis Center of Reno" in a lesser frequency.

Most popular intervention types in "Arthritis Center of Reno" are "Drug" (15 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "MM-093" (2 trials), "Abatacept" (1 trials), "Adalimumab" (1 trials) and "BCX4208" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Center of Reno" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis Center of Reno". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Arthritis Center of Reno, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Center of Reno, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".